Pfizer's Zoetis Stock Jumps After IPO Prices High
Zoetis (ZTS), the animal-health company being spun off from Pfizer (PFE), was up 18% early Friday morning after its IPO priced above the company's expected range. Zoetis raised $2.2 billion after it priced its offering of 86.1 million shares at $26 each, above its previously stated range of $22 to $25. It was the biggest IPO raise since Facebook (FB) raked in $16 billion last May. The company sold 20% of its shares, with Pfizer retaining a
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here